Camp4 Therapeutics Corp (CAMP) insider trading
Every open-market stock purchase and sale by Camp4 Therapeutics Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- 5AM Partners VI LLC (Insider) and 4 others bought $5M in the last 90 days.
- Andrew J. Schwab (Insider) and 1 other sold $2.5M in the last 90 days.
Last 12 months: insiders bought $5M (6 buys) and sold $2.5M (4 sales). Last close $3.29 on Oct 21, 2026.
Recent CAMP insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 31, 2026 | Kelly Gold (CFO) | Bought | $39.6K |
| Aug 27, 2026 | Andrew J. Schwab (Insider) | Sold | $1.6M |
| Aug 24, 2026 | Andrew J. Schwab (Insider) | Sold | $45 |
| Aug 21, 2026 | Andrew J. Schwab (Insider) | Sold | $144K |
| Aug 20, 2026 | Andrew J. Schwab (Insider) | Sold | $521K |
| Aug 19, 2026 | Andrew J. Schwab (Insider) | Sold | $215K |
| Aug 19, 2026 | Daniel Tardiff (C-suite exec) | Sold | $8.3K |
| Aug 3, 2026 | Andrew J. Schwab (Insider) | Bought (not open market) | $4.9M |
| Aug 3, 2026 | 5AM Partners VI LLC (Insider) | Bought | $4.9M |
| Aug 3, 2026 | Richard A Young (Director) | Bought | $27K |
| Aug 3, 2026 | Yuri Maricich (C-suite exec) | Bought | $10.8K |
| Aug 3, 2026 | Josh Mandel-Brehm (CEO) | Bought | $10.8K |
| Aug 3, 2026 | Kelly Gold (CFO) | Bought | $10.8K |
| Jun 10, 2026 | Amir Nashat (10% owner) | Bought (not open market) | — |
| Jun 10, 2026 | Murray Stewart (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Steven H Holtzman (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Andrew J. Schwab (10% owner) | Bought (not open market) | — |
| Jun 10, 2026 | Richard A Young (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Douglas E Williams (Director) | Bought (not open market) | — |
| Apr 1, 2026 | Michael F MacLean (Director) | Bought (not open market) | — |
| Apr 1, 2026 | Yuri Maricich (C-suite exec) | Bought (not open market) | — |
| Apr 1, 2026 | Josh Mandel-Brehm (CEO) | Bought (not open market) | — |
| Apr 1, 2026 | Kelly Gold (CFO) | Bought (not open market) | — |
| Apr 1, 2026 | Daniel Tardiff (C-suite exec) | Bought (not open market) | — |
| Dec 11, 2025 | Daniel Tardiff (C-suite exec) | Bought (not open market) | — |
Who's trading CAMP
- Kelly Gold, CFO: bought $50.4K (2 buys), last Aug 31, 2026
- Andrew J. Schwab, 10% owner: sold $2.5M (5 sales), last Aug 27, 2026
- Daniel Tardiff, C-suite exec: sold $8.3K (1 sale), last Aug 19, 2026
- Richard A Young, Director: bought $27K (1 buy), last Aug 3, 2026
- Josh Mandel-Brehm, CEO: bought $10.8K (1 buy), last Aug 3, 2026
- Yuri Maricich, C-suite exec: bought $10.8K (1 buy), last Aug 3, 2026
- 5AM Partners VI LLC, Insider: bought $4.9M (1 buy), last Aug 3, 2026
- Douglas E Williams, Director: other filings, last Jun 10, 2026
- Amir Nashat, 10% owner: other filings, last Jun 10, 2026
- Murray Stewart, Director: other filings, last Jun 10, 2026
- Steven H Holtzman, Director: other filings, last Jun 10, 2026
- Michael F MacLean, Director: other filings, last Apr 1, 2026
Get free alerts when an insider at Camp4 Therapeutics Corp files a new trade →